These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

447 related items for PubMed ID: 18772860

  • 1. Nebivolol treatment reduces serum levels of asymmetric dimethylarginine and improves endothelial dysfunction in essential hypertensive patients.
    Pasini AF, Garbin U, Stranieri C, Boccioletti V, Mozzini C, Manfro S, Pasini A, Cominacini M, Cominacini L.
    Am J Hypertens; 2008 Nov; 21(11):1251-7. PubMed ID: 18772860
    [Abstract] [Full Text] [Related]

  • 2. Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity.
    Garbin U, Pasini AF, Stranieri C, Manfro S, Boccioletti V, Cominacini L.
    Pharmacol Res; 2007 Dec; 56(6):515-21. PubMed ID: 17977009
    [Abstract] [Full Text] [Related]

  • 3. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats.
    Wang Y, Zhang M, Liu Y, Liu Y, Chen M.
    Vascul Pharmacol; 2011 Dec; 54(1-2):36-43. PubMed ID: 21167314
    [Abstract] [Full Text] [Related]

  • 4. Effect of nebivolol and metoprolol treatments on serum asymmetric dimethylarginine levels in hypertensive patients with type 2 diabetes mellitus.
    Oğuz A, Uzunlulu M, Yorulmaz E, Yalçin Y, Hekim N, Fici F.
    Anadolu Kardiyol Derg; 2007 Dec; 7(4):383-7. PubMed ID: 18065333
    [Abstract] [Full Text] [Related]

  • 5. Nebivolol reverses endothelial dysfunction in essential hypertension: a randomized, double-blind, crossover study.
    Tzemos N, Lim PO, MacDonald TM.
    Circulation; 2001 Jul 31; 104(5):511-4. PubMed ID: 11479245
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease.
    Lekakis JP, Protogerou A, Papamichael C, Vamvakou G, Ikonomidis I, Fici F, Mavrikakis M.
    Cardiovasc Drugs Ther; 2005 Aug 31; 19(4):277-81. PubMed ID: 16187009
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Pharmacological modulation of NO synthesis in patients with arterial hypertension and endothelial dysfunction].
    Buval'tsev VI, Spasskaia MB, Nebieridze DV, Metel'skaia VA, Guseva OI.
    Klin Med (Mosk); 2003 Aug 31; 81(7):51-5. PubMed ID: 12934313
    [Abstract] [Full Text] [Related]

  • 13. Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide.
    Gupta S, Wright HM.
    Cardiovasc Ther; 2008 Aug 31; 26(3):189-202. PubMed ID: 18786089
    [Abstract] [Full Text] [Related]

  • 14. Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.
    Kandavar R, Fernandez C, Sander GE, Kim C, Velaga S, Sukhanov S, Delafontaine P, Egan P, Roffidal LE, Giles TD.
    J Clin Hypertens (Greenwich); 2015 Jan 31; 17(1):14-9. PubMed ID: 25495953
    [Abstract] [Full Text] [Related]

  • 15. Genetic variation in the dimethylarginine dimethylaminohydrolase 1 gene (DDAH1) is related to asymmetric dimethylarginine (ADMA) levels, but not to endothelium-dependent vasodilation.
    Lind L, Ingelsson E, Kumar J, Syvänen AC, Axelsson T, Teerlink T.
    Vasc Med; 2013 Aug 31; 18(4):192-9. PubMed ID: 23892448
    [Abstract] [Full Text] [Related]

  • 16. Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.
    Pronko TP, Zinchuk VV.
    Clin Physiol Funct Imaging; 2009 May 31; 29(3):170-6. PubMed ID: 19170724
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension.
    Simon G, Johnson ML.
    Clin Exp Hypertens; 1993 May 31; 15(3):501-9. PubMed ID: 8098243
    [Abstract] [Full Text] [Related]

  • 20. Impaired flow-mediated dilation with age is not explained by L-arginine bioavailability or endothelial asymmetric dimethylarginine protein expression.
    Gates PE, Boucher ML, Silver AE, Monahan KD, Seals DR.
    J Appl Physiol (1985); 2007 Jan 31; 102(1):63-71. PubMed ID: 16946027
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.